Vaccine-related myocarditis associated with the BNT162b2 vaccine is a rare complication, with a higher risk observed in male adolescents. However, the contribution of genetic factors to this condition remains uncertain. In this study, we conducted a comprehensive genetic association analysis in a cohort of 43 Hong Kong Chinese adolescents who were diagnosed with myocarditis shortly after receiving the BNT162b2 mRNA COVID-19 vaccine. A comparison of whole-genome sequencing data was performed between the confirmed myocarditis cases and a control group of 481 healthy individuals. To narrow down potential genomic regions of interest, we employed a novel clustering approach called ClusterAnalyzer, which prioritised 2,182 genomic regions overlapping with 1,499 genes for further investigation. Our pathway analysis revealed significant enrichment of these genes in functions related to cardiac conduction, ion channel activity, plasma membrane adhesion, and axonogenesis. These findings suggest a potential genetic predisposition in these specific functional areas that may contribute to the observed side effect of the vaccine. Nevertheless, further validation through larger-scale studies is imperative to confirm these findings. Given the increasing prominence of mRNA vaccines as a promising strategy for disease prevention and treatment, understanding the genetic factors associated with vaccine-related myocarditis assumes paramount importance. Our study provides valuable insights that significantly advance our understanding in this regard and serve as a valuable foundation for future research endeavours in this field.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155081PMC
http://dx.doi.org/10.1186/s12863-024-01238-6DOI Listing

Publication Analysis

Top Keywords

vaccine-related myocarditis
12
functional areas
8
hong kong
8
genetic factors
8
genomic regions
8
myocarditis
5
genome-wide association
4
association study
4
study bnt162b2
4
bnt162b2 vaccine-related
4

Similar Publications

Article Synopsis
  • Researchers studied children in Ireland admitted to pediatric ICU for COVID-19 or related conditions between January 2020 and August 2022 to understand illness severity and outcomes.
  • Out of 127 children, the majority had acute COVID-19 (68.5%) or Pediatric Inflammatory Multisystem Syndrome (30.7%), with those in the PIMS-TS group requiring more intensive cardiac support.
  • Despite the high incidence of cardiac issues during hospitalization, all patients survived and showed normal heart function upon discharge.
View Article and Find Full Text PDF
Article Synopsis
  • * Data was collected from 952 patients, revealing a 2.2% incidence of vaccine-related adverse events (11 cases of myocarditis, 10 of pericarditis), most commonly following the Pfizer-BioNTech vaccine.
  • * Despite some patients experiencing symptoms and requiring hospitalization, overall prognosis remained favorable for all patients with mRNA-VRCS, with no significant differences noted in emergency room visits or mortality rates.
View Article and Find Full Text PDF
Article Synopsis
  • The document addresses the need for updated guidelines regarding the evaluation and management of pediatric patients affected by COVID-19 and its related conditions.
  • It compiles high-quality research on cardiovascular issues stemming from SARS-CoV-2 to aid primary pediatric clinicians in their decision-making.
  • Key topics include cardiac effects of acute infection, multisystem inflammatory syndrome in children (MIS-C), vaccine-related myocarditis, and considerations for returning to physical activities post-infection.
View Article and Find Full Text PDF

Numerous cases of myocarditis related to mRNA vaccines for COVID-19 have recently been described, usually in young men. Long-term evolutive cardiac magnetic resonance imaging (CMR) data are lacking. We describe four consecutive cases of COVID-19 vaccine-induced myocarditis.

View Article and Find Full Text PDF

Introduction: Myopericarditis is a rare but serious coronavirus disease 2019 (COVID-19) vaccine-related adverse event primarily affecting adolescents. Given recent approvals for childhood vaccination, we performed a meta-analysis investigating myopericarditis following messenger ribonucleic acid COVID-19 vaccination in children aged <19 years, focusing on its overall risk and high-risk subgroups.

Methods: We searched MEDLINE via PubMed, Embase and Scopus from inception to 1 August 2022 for observational studies reporting myopericarditis in temporal relation to paediatric COVID-19 vaccination.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!